Capgemini records Q1 2024 revenues of €5.5 billion in line with expectations
April 30, 2024 01:00 ET
|
Capgemini SE
Media relations:Victoire GruxTel.: +33 6 04 52 16 55victoire.grux@capgemini.com Investor relations:Vincent BiraudTel.: +33 1 47 54 50 87vincent.biraud@capgemini.com Capgemini records Q1 2024...
Capgemini réalise au 1er trimestre 2024 un chiffre d’affaires de 5,5 milliards € conforme aux attentes
April 30, 2024 01:00 ET
|
Capgemini SE
Relations presse :Victoire GruxTél. : 06 04 52 16 55victoire.grux@capgemini.com Relations investisseurs :Vincent BiraudTél. : 01 47 54 50 87vincent.biraud@capgemini.com Capgemini réalise au...
Sify reports Consolidated Financial Results for FY 2023-24
April 22, 2024 08:00 ET
|
Sify Technologies Limited
Revenue was INR 35,634 Million, an increase of 7% over last year. EBITDA was INR 6,756 Million, an increase of 7% over last year.
Osisko annonce les livraisons d’onces d’équivalent d’or pour le premier trimestre de 2024 et des mises à jour sur des actifs clés
April 08, 2024 08:00 ET
|
Redevances Aurifères Osisko Ltée
MONTRÉAL, 08 avr. 2024 (GLOBE NEWSWIRE) -- Redevances Aurifères Osisko Ltée (la « Société » ou « Osisko ») (TSX et NYSE : OR) a le plaisir de fournir une mise à jour sur ses livraisons, ses...
Osisko Announces Q1 2024 Geo Deliveries and Select Asset Updates
April 08, 2024 08:00 ET
|
Osisko Gold Royalties Ltd.
MONTRÉAL, April 08, 2024 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (the “Corporation” or “Osisko”) (OR: TSX & NYSE) is pleased to provide an update on its first quarter 2024 deliveries,...
Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results
March 14, 2024 16:05 ET
|
Evoke Pharma, Inc.
Fiscal year 2023 net product sales from prescriptions totaled approximately $5.2M, a 107% increase from 2022 Company projects $14M in net revenue for 2024 SOLANA BEACH, Calif., March 14, 2024 ...
NEURONES : + 11,1% de croissance organique en 2023
February 07, 2024 11:40 ET
|
NEURONES
INFORMATION PRESSERubrique : C.A. annuel 2023 Nanterre, le 7 février 2024 (après Bourse) + 11,1% de croissance organique en 2023 (en cours d’audit, en M€)20222023Croissancedont...
NEURONES: 11.1% organic growth in 2023
February 07, 2024 11:40 ET
|
NEURONES
PRESS INFORMATIONHeading: 2023 annual revenues Nanterre, February 7, 2024 (after trading) 11.1% organic growth in 2023 (being audited, in € millions)20222023Growthof which...
ROSEN, THE FIRST FILING FIRM, Encourages Paycom Software, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Initiated by the Firm – PAYC
November 19, 2023 13:20 ET
|
The Rosen Law Firm PA
NEW YORK, Nov. 19, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of...
NATIONALLY RANKED ROSEN LAW FIRM Encourages Paycom Software, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm – PAYC
November 16, 2023 13:55 ET
|
The Rosen Law Firm PA
NEW YORK, Nov. 16, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of...